About Novin Plasma

About Company:

Novin Plasma’s primary focus is on the production of medicines derived from human plasma, a rich source of essential proteins. Patients throughout Iran and around the world rely on plasma medicines to treat rare and life-threatening conditions such as immune deficiencies, hemophilia, and genetic emphysema. Our plasma fractionation plant, the first in Iran, will consist of more than 200 highly qualified scientists, technical professionals, and sales representatives who will all contribute to the production and distribution of plasma protein products.